The US Food and Drug Administration (USFDA) Commissioner Dr Scott Gottlieb talked about new steps to facilitate efficient generic drug review to enhance competition, promote access and lower drug prices in a statement. For many of those within the Indian pharma industry, the note is on expected ...
Read more: Will promote competition to reduce prices, reiterates USFDA in a new statement